Questions Flashcards

1
Q

pathognomic of alzheimers

A

amyloid plaques and tau proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

features: pseudodementia

A
  • short duration of dementia
  • equal effect on long and short term memory
  • amnesia conercing specific events (often emotional)
  • loss of social skills
  • equal effect on long and short term memory
  • loss of social skills in early illness
  • patient often answers “i don’t know” to questions as opposed to guessing
  • makes little effort in performing tasks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

def: pseudoparkinsonism

A

primarily associated with cognitive defecits in older patietns with depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

def: vascular dementia

A

syndromes of cognitive impairment caused by cerebrovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

presentation: vascular dementia

A

progressive stepwise deterioration in cognition usually occuring over months to years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

delirium causes mnemonic

A

Common causes of delirium can be remembered using the mnemonic DELIRIUMS:

D - Drugs and Alcohol (Anti-cholinergics, opiates, anti-convulsants, recreational)
E - Eyes, ears and emotional
L - Low Output state (MI, ARDS, PE, CHF, COPD)
I - Infection
R - Retention (of urine or stool)
I - Ictal
U - Under-hydration/Under-nutrition
M - Metabolic (Electrolyte imbalance, thyroid, wernickes
(S) - Subdural, Sleep deprivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

test for delirium

A

4AT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pressure ulcer score tool

A

waterlow score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cognitive impairment screening tool

A

cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

nutrition screening tool

A

MUST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

fitness of elderly scoring tool

A

rockwood frailty score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

oral to subcut morphine ration

A

2:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pain medication causing seizures

A

tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

seizure thrashold lowering drugs

A
  • Antibiotics: Imipenem, penicillins, cephalosporins, metronidazole, isoniazid
  • Antipsychotics
  • Antidepressents: Bupropion, Tricyclics, Venlafaxine
  • Tramadol
  • Fentanyl
  • Ketamine
  • Lidocaine
  • Lithium
  • Antihistamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

med for aggressive patient who has not resolved with de-escalation technique

A

PO/IM haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

subdural hyperdense unilateral area on CT

A

subdural haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

RF: subdural

A
  • advancing age >65
  • bleeding disorders or anticoagulant therapy
  • chronic alcohol use
  • recent trauma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

presentation: subdural haemorrhage

A
  • headache
  • nausea/vomiting
  • confusion
  • diminished eye/verbal/motor response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

phases of subdural haemorrhage

A

In the hyperacute phase (<1 hour) the clot may appear as a relatively isodense lesion, with underlying cerebral oedema. Note that patients with a SDH rarely present in the hyper-acute phase.

In the acute phase (<3 days) the classic appearance is of a crescent-shaped homogeneously hyperdense extra-axial collection over the affected hemisphere.

In the sub-acute phase (3 days to 3 weeks) there is organisation of the clot, and the density of the clot falls. The haematoma will therefore appear more isodense compared to the adjacent cortex, making identification more difficult. Contrast-enhanced CT or MRI can aid identification. There may be associated mass effect causing midline shift and sulcal effacement.

In the chronic phase (>3 weeks) the haematoma becomes hypodense relative to the adjacent cortex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

def: subdural haemorrhae

A

collection of venous blood accumulating in potential space between dura mater and arachnoid mater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

dopmaine agonist monitoring

A

impulsivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what medication should not be prescribed in parkinsons?

A

haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

pattern of lewy body dementia

A

fluctuating worsening condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

def:Lewy body dementia

A

porgressive, complex and challenging condition caused by abnormal portein called Lewy bodies inside brain cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
clinical features: Lewy bpdy dementia
* characterised by alpha-synuclein cystoplasmic inclusions (lewy bodies) in substantia nigra, paralimbic and neocortical areas * associated with Parkinsons disease * highly sensitive to neuroleptics causing seterioration in parkinsonism *
26
3 core features: Lewy body dementia
1. flucuating cognition 2. parkinsonism 3. visual hallucinations
27
scanning:Lewy body dementia
dopamine uptake scanning
28
Early movement signs: parkinsons
tremor bradykinesia rigidity postural impairment
29
pathophysiology: parkinsons
* low levels dopamine in basal ganglia (movement structures) * due to death of dopamine neurons in substantia nigra
30
hallmark brain sign of parkinsons
<50% domapine neurons in substantia nigra
31
tx: parkinsons
L-dopa crosses blood brain barrier to synthesise dopamine
32
effect of L-dopa treatment in parkinsons
* increases dompaine levels to improve movement-related problems * does not affect neurodegenration of parkinsons
33
cardinal features: parkinsons | mnemonic TRAP
Tremor Rigidity Akenesia (bradykinesia) Postural instability
34
cardinal features: parkinsons | mnemonic TRAP
Tremor Rigidity Akenesia (bradykinesia) Postural instability
35
craiofacial symptoms: parkinsons
* hypomimia * dysphagia * hypophonia * blurred vission and eyelid apraxia * shuffling, festination and freezing gait
36
how to test bradykinesia: parkinsons
finger-thumb testing quaking hand movements feet stoming
37
desribe parkinsons tremor
resting high amplitude, low frequency
38
RFs: parkinsons
* increased age * high intake dairy products * pesticides * cancer * traumatic brain injury
39
gene identified in Parkinsons
LRRK2
40
protective factors: parkinsons
tobacco coffee intake (cafffeine) high uric acid levels physical activity
41
diagnosis: parkinsons
badykinesia PLUS at least one of: tremor, rigidity or postural instability
42
non-motor signs and symptoms: parkinsons
* olfactory - hyposomia (can preceed motor symptoms couple of years) * cognitive impairment (memory) * psychiatric - hallucinations, depression * autonomic dysfunction - postural hypotension * pain - shoulder girdle from bradykinesia * fatigue - usually during day * sleep disturbance (REM sleep) * speech- quiet voice
43
medical initiation treatment: parkinsons
* levodopa and decarboxylase inhibitor * dopamine agonist * MAOI
44
advjuvant treatment: parkinsons
* COMT inhibitor (entacapone - decreases peripheral levodopa breakdown) * amantadine * apomorphine
45
describe parkinsons tremor
* 4-6Hz * pill rolling * worse at rest * asymmetrical
46
describe parkinsons regidity
lead pipe cogwheel
47
describe parkinsons bradkinesia
micrographia hypomimia festinating gait reduced arm swing
48
tx: parkinsons not impacting life
MAO-B - selegline or dopamine agonist - ropinirole or rotigotine
49
when is selegiline contraindicated in non-life impacting parkinsons treatment
SSRI
50
tx: parkinsons symptoms impacting life
levodopa + dopa-decarboxylase inhibitor (carbidopa)
51
side effects: levodopa and carbidopa in parkinsons
* N+V * postural BP * oedema * confusion * visual hallucinations * red urine * drowsiness * dyskinesia * wearing off * freezinf
52
what happens in Levodopa dose is missed in parkinsons
neuroleptic malignant syndrome
53
what is neuroleptic malignant syndrome?
life-threatening neurologic emergency associated with the use of antipsychotic (neuroleptic) agents and characterized by a distinctive clinical syndrome of mental status change, rigidity, fever, and dysautonomia (fast HR, irregular HR and tachypnoea)
54
what is neuroleptic malignant syndrome?
life-threatening neurologic emergency associated with the use of antipsychotic (neuroleptic) agents and characterized by a distinctive clinical syndrome of mental status change, rigidity, fever, and dysautonomia (fast HR, irregular HR and tachypnoea)
55
tx: daytime sleepiness parkinsons
medafinil
56
tx: REM parkinsons
melatonin or clonazepam
57
tx: orthostatic hypotension parkinsons
fludrocortisone
58
tx: restless leg syndrome parkinsons
gabapentin
59
tx: essential tremor ## Footnote (essential tremor - symmetrical and postural, improves with alcohol)
propranolol
60
def: essential tremor
symmetrical, postural and improves with alcohol
61
def: drug induced parkinsonism
bilateral, subacute, postural tremor
62
causes: drug induced parkinsonism
* antipsychotics * antiemetics * valproate * fluoxetine * CCBs and * amiodarone
63
tx: dopamine psychosis
, olanzapine, quetiapinedrug withdrawal - slowly reduce stimuli antipsychotic agents - clozapine
64
signs of hedonistic dopamine dysregulation syndroem
* OCD - punding (repetitive/mindless behaviours - dimantiling, DIY, collecting, sorting) or walkabout * Risk behaviour - grandiose business plans * appetite alterations (weight loss or food cravings) * hypomania/ psychosis * gambling * hypersexuality
65
Braak's hypothesis of Parkinsons
stage 1 - changes in dorsal nucleus and olfactory bulb stage 2 - lewy body formation in pons and medulla stage 3 and 4 - motor symptoms stage 5 and 6 - cognitive and dementia signs
66
4 types of parkinson plus syndromes
1. progressive spuranuclear palsy 2. mutiple system atrophy 3. corticobasal degenration 4. lewy body dementia
67
features: progressive supranuclear palsy parkinson's plus syndrome
vertical gaze palsy with parkinsonism
68
features: mustiple system atrophy PPS
postural hypotension, incontinence and impotence plus parkinsonism
69
features: cortico-basal degeneration PPS
parkinsonism and spontaneous activity or affected limb or akinetic rigidty of limb
70
features: lewy bosy dementia PPS
parkinsonism plus fluctuations in cognitive impairment and visual hallucinations often before parkinsonism features occur
71
what can be given instead of haloperidol in parksinsons
lorazepam
72
drugs to review in elderly (STOPP/START)
* Diuretics * Antidepressants * Antipsychotics * Hypnotics * Digoxin * NSAIDs * Hypotensive agents * Drugs for Parkinson’s disease
73
causes of transient incontinence | DIAPPERS
* delirium * infection * atrophic urethritis/vaginitis * pharmaceutical * psychological * excessive urinary output * reduced mobility * sstool impaction
74
symptoms: overactive bladder syndrome
* sudden desire to void * often have nocturia * frequent, periodic incontinentepisodes (wet OAB) * may not be incontinent (dryOAB)
75
how is detrusor overactivity demonstrated
urodynamics
76
def: reflex urinary incontinence
* sudden loss of control of bladder * no prior awareness of need to micturate * neurological problem (MS, parkinsons, brain tumour, spinal cord injuries)
77
def: stress incontinence
* when standing, physical activity, coughing or laughing causes urine leakage * usually due to weakness in pelvic floor/sphincter damage
78
def: urethral obstruction - overflow incontinenec
* common in eldery men * post void dribbling *
79
causes: urethral obstruction
neuro: spinal cord lesions non-neuro: prostate enlargement, urethral stricture, adrenergic agonist medications, tumours
80
def: functional incontinence
lower urinary tract intact poor mobility, poor dexterity, poor cognition
81
def: mixed incontinence
any incontinence causes in combination
82
drugs causing incontinence
* diuretics * anticholinergics - esp haloperidol - cause retention * opiates - constipation - overflow incontinence * alcohol and caffeine * alpha blocks - relax bladder outlet * alpha agonists - urinary retention causing overflow
83
examination: incontinence
* functional status * cognitive status * neuro * rectal exam - prostate size * pelvic exam - cystocele, rectocele, atrophic vaginits
84
inv: incontinece
* MSSU * post void residual volume * uroflowometry * cystometry * vaginal cytology * urodynamics * U+E, CA, serum glucose
85
tx: OAB
* bladder training and prompted voiding * anti-muscarinics - oxybutanin, derifenacin * mirabegron - beta 3 agonist
86
tx: stress incontinence
weight loss treat cough pelvic floor excercises duloxetine and oestrogern surgery
87
def: stroke
acute neurological event due to cerebrovascular pathology >24hrs
88
RFs: stroke
* HTN * smoking * AF * DM * hyperlipiaemia * anticoagulation
89
what does ischaemic strokw look like on CT
hypodense
90
causes: ischaemic stroke
emboli from AF infective endocarditis valve disorder air embolus fat embolus
91
causes: haemorrhagic stroke
sponaneous aneurysm rupture SAH
92
haemorrhagic stroke on CT
hyperdense
93
management: stroke
* urgent CThead to exclude bleed * FBC, U+E, ESR, glucose * BP * NBM until formal SALT test * ECG * echo * carotid artery dopplers *
94
tx: ischaemic stroke
* admit to stroke unit * alteplase (0.9mg/kg to 90mg max) lysis within 4.5 hours * thrombectomy within 24 hours * aspiri 300mg for 2 weeks * mechanical leg compressors rahter than prophylactic clexane
95
what should be done before first dose 300mg aspirin after ischaemix stroke
rescan after 24 hours before aspirin dose in case of haemhorrage
96
tx: haemhorragic stroke
BP control 140-150mmHg stop and reverse anticaogulants
97
longterm tx: stroke
atorvastatin 80mg clopidogrel 75mg physio OT SALT
98
indication: carotid endarterectomy
if>50% after TIA
99
what is contraindicatcated 10-14 days post stroke/TIA
anticoagulation
100
bamford stroke classification
TACS - ALL 3 of 1. unilateral weakness (and/or sensory defecit) of the face, arm and leg 2. homonymous hemianopia 3. higher cerebral dysfunction (dysphasia, visuospatial disorder) PACS - 2 of the TACS LACS - one of 1. pure motor, 2. pure sensory, 3. sensori-motor, 4. ataxic hemiparesis POCS - one of: 1. cranial nerve palsy and contralateral motor/sensory defecit 2. bilateral motor/sensory defecit 3. conjugate eye movement disorder (gaze palsy) 4. cerebellar dysfunction - ataxia, nystagmus or vertigo and 5. isolated homonymous hemianopia or cortical blindness
101
TACS
TACS - ALL 3 of 1. unilateral weakness (and/or sensory defecit) of the face, arm and leg 2. homonymous hemianopia 3. higher cerebral dysfunction (dysphasia, visuospatial disorder)
102
PACS
2 of 3 of 1. unilateral weakness (and/or sensory defecit) of the face, arm and leg 2. homonymous hemianopia 3. higher cerebral dysfunction (dysphasia, visuospatial disorder)
103
LACS
one of 1. pure motor, 2. pure sensory, 3. sensori-motor, 4. ataxic hemiparesis
104
POCS
one of: 1. cranial nerve palsy and contralateral motor/sensory defecit 2. bilateral motor/sensory defecit 3. conjugate eye movement disorder (gaze palsy) 4. cerebellar dysfunction - ataxia, nystagmus or vertigo and 5. isolated homonymous hemianopia or cortical blindness
105
scoring tools for risk stratification after stroke
CHA2DS2VASc CHF Hypertension Age >75 2 DM Stroke 2 Vascular disease Age 65-74 Sex HASBLED Hypertension Abnormal liver/renal fnx Stroke Bleeding tendency Labile INR Age >65 Drugs (aspirin or NSAIDs or alcohol)
106
contraindications: thrombolysis in stroke
* bleed * seziures at presentation * HTN >180/100 * NIHSS >25 * LP in past week * stroke/head injury in past 3 months * surgery trauma within past 2 weeks
107
alteplase dosing in stroke
0.9mg/kg upo to 90mg
108
delirium casues mnemonic
PINCH ME pain infection nutrition constipation hydration medication environment
109
screening for delirium
4AT
110
Rockwood frailty scoring
1 - very fit (fittest for their age) 2 - well (no active disease but less fit than 1 seasonally active 3 - managing well - medical problems well controlled, not regularly active 4 - vulnerable - not dependent for daily things, symptoms limit activities "slowed up" 5 - mildly frail - more evident slowing and need help with high order IADLs - finances, transport, heavy housework etc - shopping and walking outside alone, meal prep and housework impaired 6 - moderatley frail help with all outside activities and keeping house. help with bathing and minimal assistance dressing. problems with stairs 7 - severely frail - completely dependent for personal care (not high risk dying within 6 months) 8 - very severely frail - completely dependent and approaching wend of life - couldn't recover from minor illness 9 - terminally ill - approaching end oflife - life expectancy <9months
111
certification of life extinct
1. no heart sounds after 3 mins ausc 2. 2. no breath sounds 3. no respiratory effort 4. no central pulse 5. pupils fixed and dilated 6. no response to stimuli/pain
112
what scan is used in perkinsons
DaT
113
def: dementia
gradual decline in 2+ areas of cognition (memory, personality, behaviour) that affects ADLs
114
screening tool and score for dementia
MMSE 24/30 or less suggestive Addenbrooks <85 suggests cognitive impair
115
def: Alzheimer's dimentia
global, progressive, amnesia, aphasia, agnosia, apraxia, apathy worse in evening (sundowning)
116
RFs: alzheimers dimetnia
* HTN * DM * FHx * Doen's * brain injury * female * >65yrs
117
pathophys: alzheimers dimentia
amyloid and tau proteins (plaquesand neurofibrillary tangles) in cortex and hippocampus
118
tx: alzheimer's dimentia
acetylcholinesterase inhibitors(donezepil, galantamins, rivastigmine) memantinein severe
119
def: vascular dimentia
step-wise, rapid, preserved personality/insight, focal neurology
120
criteria for vascular dimentia
NINDS-AIREN
121
RFs: vascular dimentia
IHD, smoking, DM, obesity, Af
122
causes of vascular dimentia
accumulation of strokes or TIAs
123
def: Lewy body dementia
fluctuating cognition, lucid periods, visual hallucinations, prkinsonism, lack of REM sleep
124
pathophys: LB dementia
alpha synuclein ubiquitin aggregation in sustantia nigra
125
tx: LB dementia
acetylcholinesterase inhibitors memantine
126
def: frontotemporal dementia
personality/speech affected first disinhibited onset <65yrs autosomal dominant
127
pathophys frontotemporal dementia
atrophy of frontotemproal lobes - knife blade appearance (Picks dx
128
tx: frotnotemporal dementia
none available
129
def Charles Bonnet syndrome
Charles Bonnet Syndrome presents with visual hallucinations in a patient with bilateral visual loss, typically secondary to glaucoma or cataracts. Importantly, the patient has insight and no other psychiatric or cognitive symptoms.
130
what abx to avoid in epilepsy
ciprofloxacin